Kenz Cream contains Ketoconazole 2% w/w, an antifungal agent effective against a broad spectrum of dermatophytes, yeasts, and molds. It is primarily indicated for the topical treatment of superficial fungal infections such as tinea corporis, tinea cruris, tinea pedis, and pityriasis versicolor. Ketoconazole exerts its antifungal action by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Kenz Cream is applied once or twice daily to the affected area and surrounding skin, ensuring thorough coverage to maximize therapeutic efficacy. The formulation is intended for external use only and should be used consistently for the full prescribed duration to prevent recurrence. Common adverse effects are generally mild and may include local irritation, burning sensation, or itching at the application site. Patients should avoid contact with eyes and mucous membranes, and in case of accidental exposure, rinse thoroughly with water. Kenz Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any cream excipients. It is advisable to consult a healthcare professional before use, especially in pregnant or lactating women. Proper hygiene and adjunctive measures are recommended to enhance treatment outcomes.